Impact of Enhanced Daily Disinfection on Environmental Contamination in Hospital Rooms
Launched by DUKE UNIVERSITY · Feb 13, 2023
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether using a stronger disinfectant every day in hospital rooms can help reduce germs and bacteria compared to the usual cleaning methods. The goal is to see if this enhanced cleaning process makes the environment safer for patients who are staying in these rooms.
To be eligible for this trial, participants need to be adults who have been admitted to a hospital room and plan to stay for at least two nights. They also need to be on contact precautions, which means extra measures are in place to prevent the spread of infections. Unfortunately, patients who are expected to stay less than two nights, those under 18 years old, or those admitted due to specific respiratory illnesses like COVID-19 will not be able to participate. If you join the study, you can expect to be part of a team working to improve hospital safety and cleanliness for everyone.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patient admitted to the room
- • Patient spent ≥1 night in room prior to enrollment
- • Anticipated patient stay of ≥48 hours
- • On contact precautions (for any reason) and/or has positive culture for EIP at the time of room admission
- Exclusion Criteria:
- • Patient stay is expect to be \<48 hours
- • Patient age \<18, even if on adult ward
- • Patient admitted on respiratory precautions due to coronavirus disease (COVID-19), influenza, or respiratory syncytial virus (RSV)
- • Patient on contact precautions due to C. difficile
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Durham, North Carolina, United States
Patients applied
Trial Officials
Deverick Anderson, MD
Principal Investigator
Duke University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials